2016 VAM: 2307 - What Do I Do With These Abnormal Newborn Screening Results?
Provide clinicians with the information needed to better treat newborns with abnormal screening results, and will discuss options for novel therapies.
AMA PRA Category 1 Credits™: 1.25
CE: 1.25
Credit must be claimed by May 31, 2018. Any credit request on or after June 1, 2018 will be subject to an administrative fee.
Target Audience
Physicians
Allergists/Immunologists
Nurses
Nurse Practitioners
Allied Health Professionals
Learning Objectives
1. Identify the incidence of SCID and survival outcomes after implementation of newborn screening programs
2. Identify idiopathic lymphopenia, dilemmas and strategies for management
3. Discuss various transplantation protocols and new experimental treatment options for SCID
Additional Information
Attachment | Size |
---|---|
2016 Annual Meeting Disclosures | 120.13 KB |
Dr. Vincent R. Bonagura, MD FAAAAI, North Shore Long Island Jewish Health System, Great Neck, NY
Donald B. Kohn, MD, University of California, Los Angeles
Dr. Kathleen E. Sullivan, MD PhD FAAAAI, The Children's Hospital of Philadelphia, Philadelphia, PA
Available Credit
- 1.25 AttendanceAttendance credit.
- 1.25 CECE credit.
- 1.25 CMECME credit.